Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME Dermatan sulfate hydrolytic enzyme DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Mucopolysaccharidosis I 3 D008059 ClinicalTrials
Mucopolysaccharidosis I 3 D008059 ClinicalTrials
Mucopolysaccharidosis I 3 D008059 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
16.33
Respiratory, thoracic and mediastinal disorders
12.09
Nervous system disorders
9.92
Infections and infestations
8.29
Injury, poisoning and procedural complications
5.88
Gastrointestinal disorders
5.68
Cardiac disorders
5.67
Musculoskeletal and connective tissue disorders
5.49
Vascular disorders
4.15
Skin and subcutaneous tissue disorders
3.92
Investigations
3.44
Eye disorders
3.36
Surgical and medical procedures
3.12
Psychiatric disorders
2.88
Immune system disorders
2.42

Cross References

Resources Reference
CAS NUMBER 210589-09-6
ChEMBL CHEMBL1201595
FDA SRS WP58SVM6R4